Astrea Bioseparations (Cambridge, UK) has announced that it has expanded its manufacturing and warehousing capabilities in the US.
Team integration into a company. Joining specialists and professionals. Employment hiring workers. Human resources. New experience. Personel growth. Management appointment. New members | Image Credit: © Andrii Yalanskyi - stock.adobe.com
Located in Canton, Massachusetts, the 12,000-square-foot facility will expand the company’s US footprint and increase its workforce up to 9% over an 18‑month period. It will feature cleanroom laboratories for column packing services, offices, warehousing, and column assembly spaces.
“Expanding our presence in the US reflects growing demand for our chromatography products and services to support effective development and production of cutting-edge biologics, including cell and gene therapies,” said Chris Brown, operations director at Astrea Bioseparations. “The new site gives us greater capacity to support new and existing customers by providing innovative and high‑quality products, within market‑leading time frames, as well as offering local technical expertise.”
For more information, please visit: www.astreabioseparations.com
Targeted Blood Lipidomics of Colorectal Cancer: An HTC-18 Interview with Jef Focant
July 26th 2024At HTC-18 in Leuven, Executive Editor of LCGC International, Alasdair Matheson, spoke to Jef Focant from the University of Liege about his talk entitled, “Targeted Blood Lipidomics of Colorectal Cancer."
Carol Robinson Awarded 2024 Lifetime Achievement European Inventor Award
July 24th 2024Carol Robinson of the University of Oxford has received the European Inventor Award 2024 for Lifetime Achievement from the European Patent Office for her work bringing mass spectrometry to structural biology.